A new vaccine being reviewed at Stanford may soon get FDA approval, hoping to aid the slow vaccine rollout problem.
ADVERTISEMENT
ADVERTISEMENT
New COVID-19 Vaccine Studied by Stanford Doctors Offers New Hope
A new vaccine being reviewed at Stanford may soon get FDA approval, hoping to aid the slow vaccine rollout problem.